Referral of pediatric laundry detergent pack exposure reported to poison centers

Mathias B Forrester1

  • 1Department of State Health Services, Austin, Texas.

Insights

Laundry detergent pack exposures in children under five are concerning. Serious outcomes and specific symptoms like ocular irritation or lethargy significantly increase the likelihood of referral to healthcare facilities.

Area of Science:

  • Toxicology
  • Pediatric Emergency Medicine
  • Public Health

Background:

  • Concentrated laundry detergent packs present new risks for pediatric poisoning compared to traditional detergents.
  • Young children are particularly vulnerable to adverse effects from these products.

Purpose of the Study:

  • To investigate factors associated with poison center referrals for pediatric laundry detergent pack exposures.
  • To identify characteristics of exposures that predict the need for healthcare facility evaluation.

Main Methods:

  • Retrospective analysis of pediatric laundry detergent pack exposures (patients ≤5 years) reported to Texas poison centers (Feb 2012–Aug 2013).
  • Calculation of healthcare facility referral rates based on patient age, outcome severity, product brand, exposure route, and clinical effects.

Main Results:

  • Out of 912 exposures, 192 (21%) were referred to healthcare facilities.
  • Referral rates were higher for serious outcomes (71.6%) and infants under 1 year (32.0%).
  • Specific clinical effects like drowsiness (67.5%) and dermal edema (68.4%) were strongly associated with referrals.

Conclusions:

  • Pediatric laundry detergent pack exposures necessitate careful evaluation, with higher referral rates for severe outcomes and specific clinical presentations.
  • Factors such as brand (Purex™), ocular exposure, and neurological or dermal effects increase referral likelihood.
  • These findings highlight the importance of prompt medical assessment for significant pediatric exposures to laundry detergent packs.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
268
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
998
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K